Centene Corporation announced that its subsidiary, Meridian in Michigan (Meridian), has been selected by the Michigan Department of Health and Human Services (MDHHS) to continue to serve as a Medicaid health plan for the Comprehensive Health Care Program, which serves nearly 2 million Michiganders statewide. The proposed Medicaid contracts are expected to begin on October 1, 2024, and run through September 30, 2029, with three, one-year optional extensions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.85 USD | -0.07% | +4.98% | +2.21% |
05-02 | Barclays Adjusts Price Target on Centene to $104 From $101 | MT |
04-30 | Bernstein Adjusts Centene's Price Target to $94 From $100 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.21% | 40.48B | |
-4.42% | 463B | |
+13.10% | 124B | |
+16.00% | 98.67B | |
-29.20% | 39.06B | |
-4.68% | 20.18B | |
-13.50% | 3.09B | |
-21.25% | 1.3B | |
-8.56% | 432M |
- Stock Market
- Equities
- CNC Stock
- News Centene Corporation
- Centene Corporation Subsidiary Meridian in Michigan Receives Michigan Medicaid Contracts